Vivex Biologics’ VIA Form+ cryopreserved viable bone allograft saw 100% radiograhpic fusion success within six months of surgery, according to a study in the Journal of Spine & Neurosurgery. Five ...
Medtronic (NYSE: MDT) announced today that it received FDA premarket approval (PMA) for the use of its Infuse bone graft in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results